q-122
Vasomotor Symptoms (VMS)
Que OncologyPhase 2Dormant
BB
64/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 49/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Vasomotor Symptoms (VMS) cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Fezolinetant Shehzad Basaria, M.D. | Phase 2 | CCC |
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →